Elephas Biosciences Corporation: Valuation, Funding & Investors
Elephas Biosciences Corporation has developed an innovative live tumor profiling platform for immunotherapy response prediction. The platform enables real-time characterization of immune response by preserving the native tumor microenvironment from a live core needle biopsy and addressing tumor heterogeneity.
Leadership & Board
- Current Number of Employees
- 158
- Current LinkedIn Followers
- 6,781
Latest Estimated Valuation
- Total Amount Raised
- $40M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $40M
- Latest Funding Round
- Series B
Company Momentum
PositiveElephas Biosciences Corporation LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Elephas Biosciences Corporation had 158 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Elephas Biosciences Corporation had 6,781 followers as of November 16, 2026. The number of followers increased by 13 (0.19%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Nov 06, 2025 | Series B | $40.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Sands Capital | Series B |
| State of Wisconsin Investment Board | Series B |
| ARCH Venture Partners | Series B |
| Northpond Ventures | Series B |
| Tao Capital Partners | Series B |
Similar Companies
A snapshot of private companies similar to Elephas Biosciences Corporation, helping you discover and navigate related company profiles.
Related News and Analysis









